copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Johnson Johnson Reports Q2 2025 Results; Raises 2025 Outlook NEW BRUNSWICK, N J -- (BUSINESS WIRE)-- Johnson Johnson (NYSE: JNJ) today announced results for second-quarter 2025 “Today’s strong results reflect the depth and strength of Johnson Johnson’s uniquely diversified business operating across both MedTech and Innovative Medicine,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson Johnson “Our portfolio and
Contact us - Johnson Johnson Get in touch with Johnson JohnsonDo not sell or share my personal information Limit the use of my sensitive personal information
Johnson Johnson Reports Q4 and Full-Year 2024 Results NEW BRUNSWICK, N J -- (BUSINESS WIRE)-- Johnson Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024 "2024 was a transformative year for Johnson Johnson, marked by strong growth, an accelerating pipeline and industry-leading investments in innovation,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson Johnson “As a healthcare company
Global Johnson Johnson websites If you don’t see your country or region represented above, please click below to find links to the company’s Innovative Medicine and MedTech country and regional websites
Products - Johnson Johnson Learn about Johnson Johnson's extensive portfolio of healthcare products Find solutions to meet your medical and wellness needs
Johnson Johnson: Changing health for humanity Johnson Johnson MedTech innovates at the intersection of biology and technology With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases Healthcare areas include: Cardiovascular, Orthopaedics, Surgery and